Skip to main content
Log in

Down-regulated β-adrenoceptors in severely failing human ventricles: Uniform regional distribution, but no increased internalization

  • Original Contributions
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Summary

In chronic heart failure cardiac β-adrenoceptors are decreased. In this study we investigated whether a) in severely failing human ventricles β-adrenoceptors are uniformly decreased or regional variations exist, and b) the β-adrenoceptor decrease is caused by increased internalization or is a real loss in β-adrenoceptors. For this purpose we assessed β-adrenoceptor number and subtype distribution in a particulate fraction (mainly sarcolemmal plasma membranes) and a light vesicle fraction of right and left ventricular segments (obtained by cutting transversal, rings of 2 cm from the midventricular regions) of explanted hearts from 2 patients with end-stage congestive dilated cardiomyopathy (DCM) and one patient with end-stage ischemic cardiomyopathy (ICM). In all three hearts ventricular β-adrenoceptor number was very low (7.5–10 and 21–26 fmol/mg protein in DCM, 15–22 fmol/mg protein in ICM compared to 68–74 fmol/mg protein in non-failing ventricles). β-Adrenoceptors were uniformly decreased over the whole ventricular region and no considerable regional variations existed. The same held true for β1- and β2-adrenoceptors. In ICM decrease in β-adrenoceptors was due to a concomitant reduction in β1- and β2-adrenoceptors, in DCM it was mainly caused by β1-adrenoceptor down-regulation. In all ventricular segments investigated light vesicle β-adrenoceptors amounted to about 5–7% of total ventricular β-adrenoceptors and this was not significantly different from non-failing left ventricles. We conclude that a) in severely failing human ventricles β-adrenoceptors are evenly down-regulated and no regional variations exist and b) the decrease in β-adrenoceptors is not due to enhanced internalization but is a real loss of β-adrenoceptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DCM:

dillted cardiomyopathy

ICM:

ischemic cardiomyopathy

ICI 118,551:

erythro-(±)-1-(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol hydrochloride

CGP 12177:

(±)-4-(3-tertiarybutylamino-2-hydroxypropoxy)-benzimidazole-2-on hydrochloride

ICYP:

(−) [125I]-Iodocyanopindolol

References

  1. Bilski AJ, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a β1-selective adrenoceptor antagonist (ICI 118, 551). J Cardiovasc Pharmacol 5:430–437

    Google Scholar 

  2. Böhm M, Pieske B, Schnabel P, Schwinger, R, Kemkes B, Klövekorn W-P, Erdmann E (1989) Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved, β2-adrenoceptor subpopulation. J Cardiovasc Pharmacol 14:549–559

    Google Scholar 

  3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Google Scholar 

  4. Bristow MR, Anderson FL, Port JD, Skerl L, Hershberger RE, Larrabee P, O'Connell JB Renlund DG, Volkman K, Murrary J Feldman AM (1991) Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 84:1024–1039

    Google Scholar 

  5. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison SC, Stinson EB (1982) Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. New Engl J Med 307:205–211

    Google Scholar 

  6. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB (1986) β1- and β2-adrenoceptors subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β2-receptor down-regulation in heart failure. Circ Res 59:297–309

    Google Scholar 

  7. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM (1990) β-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 82 (Suppl I):I-12–I-25

    Google Scholar 

  8. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, Fowler M, Ginsburg R (1992) β-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89:803–815

    Google Scholar 

  9. Brodde O-E (1991) β1- and β2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203–242

    Google Scholar 

  10. Brodde O-E, Zerkowski H-R, Borst HG, Maier W, Michel MC (1989) Drug- and disease-induced changes of human cardiac β1- and β2-adrenoceptors. Eur Heart J 10 (Suppl B):38–44

    Google Scholar 

  11. Brodde O-E, Zerkowski H-R, Doetsch N, Motomura S, Khamssi M, Michel MC (1989) Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta1- and beta2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 14:323–331

    Google Scholar 

  12. Chidsey CA, Braunwald E (1966) Sympathetic activity and neurotransmitter depletion in congestive heart failure. Pharmacol Rev 18:685–700

    Google Scholar 

  13. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819–823

    Google Scholar 

  14. Collins S, Bouvier M, Bolanowski MA, Caron MG, Lefkowitz RJ (1989) cAMP stimulates transcription of the β2-adrenergic receptor gene in response to short-term agoninst exposure. Proc Natl Acad Sci USA 86:4853–4857

    Google Scholar 

  15. Denniss AR, Colucci WS, Allen PD, Marsh JD (1989) Distribution and function of human ventricular beta adrenergic receptors in congestive heart failure. J Mol Cell Cardiol 21:651–660

    Google Scholar 

  16. Hadcock JR, Malbon CC (1988) Dow-regulation of β-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. Proc Natl Acad Sci USA 85:5021–5025

    Google Scholar 

  17. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73:615–621

    Google Scholar 

  18. Hausdorff WP, Caron MG, Lefkowitz RJ (1990) Turning off the signal: desensitization of β-adrenergic receptor, function. FASEB J 4:2881–2889

    Google Scholar 

  19. Hertel C, Perkins JP (1984) Recepttor-specific, mechanisms of desensitization of β-adrenergic receptor function. Mol Cell Endocrinol 37:245–256

    Google Scholar 

  20. Hough C, Chuang D-M (1990) Differential down-regulation of β1- and β2-adrenergic receptor mRNA in C6 glioma cells. Biochem Biophys Res Commun 170:46–52

    Google Scholar 

  21. Jones CR, Molenaar P, Summers RJ (1989) New views of human cardiac β-adrenoceptors. J Moll Cell Cardiol 21:519–535

    Google Scholar 

  22. Levine TB, Francis GS, Goldsmith SR, Simon, AB, Cohn JN (1982) Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49:1659–1666

    Google Scholar 

  23. Limas CJ, Limas C, Goldenberg IF (1989) Intracellular distribution of adrenoceptors in the failing human myocardium. Am Heart J 117:1310–1316

    Google Scholar 

  24. Michel MC, Maisel AS, Brodde O-E (1990) Mitigation of β1- and/or β2-adrenoceptor function in human heart failure. Br J Clin Pharmacol 30 (Suppl 1):37S-42S

    Google Scholar 

  25. Michel MC, Pingsmann A, Beckeringh JJ, Zerkowski H-R, Doetsch N, Brodde O-E (1988) Selective regulation of β1- and β2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment. Br J Pharmacol 94:685–692

    Google Scholar 

  26. Petch MC, Nayler WG (1979) Uptake of catecholamines by human cardiac muscle in vitro. Br Heart J 41:336–339

    Google Scholar 

  27. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 51:660–672

    Google Scholar 

  28. Steinfath M, Danielsen W, Von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H, Starbatty J, Stein B, Döring V, Kalmar P, Haverich A (1992) Reduced β1- and β2-adrenoceptors-mediated positive inotropic effects in human end-stage heart failure. Br J Pharmacol 105:463–469

    Google Scholar 

  29. Steinfath M, Geertz B, Schmitz W, Scholz H, Haverich A, Breil I, Hanrath P, Reupcke C, Sigmund M, Lo H-B (1991) Distinct down-regulation of cardiac β1- and β2-adrenoceptors in different human heart diseases. Naunyn-Schmiedeberg's Arch Pharmacol 343:217–220

    Google Scholar 

  30. Steinfath M, Lavicky J, Schmitz W, Scholz H, Döring V, Kalmar P (1992) Regional distribution of β1- and β2 in the failing and nonfailing human heart. Eur J Clin Pharmacol 42:607–612

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pitschner, H.F., Droege, A., Mitze, M. et al. Down-regulated β-adrenoceptors in severely failing human ventricles: Uniform regional distribution, but no increased internalization. Basic Res Cardiol 88, 179–191 (1993). https://doi.org/10.1007/BF00798266

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00798266

Key words

Navigation